The price tag on progress--chemotherapy for colorectal cancer - PubMed (original) (raw)

Comment

. 2004 Jul 22;351(4):317-9.

doi: 10.1056/NEJMp048143.

Affiliations

Comment

The price tag on progress--chemotherapy for colorectal cancer

Deborah Schrag. N Engl J Med. 2004.

No abstract available

Cetuximab in colon cancer.
Holmer AF. Holmer AF. N Engl J Med. 2004 Oct 7;351(15):1575-6; author reply 1575-6. doi: 10.1056/NEJM200410073511519. N Engl J Med. 2004. PMID: 15470223 No abstract available.
Cetuximab in colon cancer.
Martin MJ. Martin MJ. N Engl J Med. 2004 Oct 7;351(15):1575-6; author reply 1575-6. N Engl J Med. 2004. PMID: 15473023 No abstract available.
Cetuximab in colon cancer.
Costa AF, Sander GB, Picon PD. Costa AF, et al. N Engl J Med. 2004 Oct 7;351(15):1575-6; author reply 1575-6. N Engl J Med. 2004. PMID: 15473024 No abstract available.

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cunningham D, et al. N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025. N Engl J Med. 2004. PMID: 15269313 Clinical Trial.